Advertisement

Related Videos

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Deborah Collyar: What's In It for Patients?

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Advertisement

Advertisement




Nov
05
Today In Oncology
Basser Center for BRCA Awards 2026 Global Prize
Triplet Therapy With Abiraterone Improves OS Long-Term in Metastatic Castration-Sensitive Prostate Cancer
Phase III VOLGA Trial Explores Outcomes in Muscle Invasive Bladder Cancer
First-Line Pembrolizumab Improves Progression-Free Survival in dMMR Advanced Endometrial Cancer
Bispecific ADC May Offer New Treatment Option for HR-Positive, HER2-Negative Breast Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo